<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>HKLLP.com - Vocus Press Release Account Feed</title>
<link>http://www.rsspad.com/rss2a/577924.xml</link>
<description>HKLLP.com - Press Releases</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
     <title>Hissey Kientz, LLP Announces the Launch of Digitek Recall Help Web Site</title>
     <link>http://www.prweb.com/releases/2008/09/prweb1370794.htm</link><description>   <![CDATA[ <P>The law firm of Hissey Kientz, LLP has announced the launch of its new website, Digitek Recall Help (http://www.digitekrecallhelp.com). Digitek is a form of the heart medication digoxin, which is used to treat patients with an irregular heartbeat or congestive heart failure. The drug&#039;s manufacturer issued a nationwide Digitek recall  after receiving several reports of injuries or illnesses among patients. (PRWeb Sep 23, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/09/prweb1370794.htm">http://www.prweb.com/releases/2008/09/prweb1370794.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2008/09/prweb1370794.htm</guid>
        </item>
<item>
     <title>Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity</title>
     <link>http://www.prweb.com/releases/2008/08/prweb1190604.htm</link><description>   <![CDATA[ <P>Hissey Kientz, LLP is concerned that despite a recent recall notice for the heart drug Digitek, the drug&#8217;s manufacturer has failed to provide any additional information on how long the heart medication was being improperly manufactured. According to a press release issued by the manufacturer, some Digitek tablets may have been manufactured at double their normal strength, meaning that patients could receive a double dose of the drug, leading to an overdose. A Digitek overdose could lead to severe side effects, including heart attack, stroke or death. (PRWeb Aug 16, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/08/prweb1190604.htm">http://www.prweb.com/releases/2008/08/prweb1190604.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2008/08/prweb1190604.htm</guid>
        </item>
<item>
     <title>Thousands Still Not Warned of Hepatitis Exposure at Las Vegas Clinics</title>
     <link>http://www.prweb.com/releases/2008/05/prweb942214.htm</link><description>   <![CDATA[ <P>Two Las Vegas clinics are linked to an outbreak of hepatitis C and HIV. The Nevada  Health District sent more than 40,000 &quot;Dear Patient&quot; letters to those treated after March 2004 . Patients treated before March 2004 have not been warned that they are at risk of infection of these contagious diseases. (PRWeb May 22, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb942214.htm">http://www.prweb.com/releases/2008/05/prweb942214.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2008/05/prweb942214.htm</guid>
        </item>
<item>
     <title>Drug Companies Seek to Invoke Shield Law of Preemption</title>
     <link>http://www.prweb.com/releases/2008/05/prweb945174.htm</link><description>   <![CDATA[ <P>An anticipated US  Supreme Court ruling may prevent victims injured by the Ortho Evra patch and other harmful drugs from having their day in court, according to Hissey Kientz, LLP. (PRWeb May 15, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb945174.htm">http://www.prweb.com/releases/2008/05/prweb945174.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2008/05/prweb945174.htm</guid>
        </item>
</channel>
</rss>